The tension resulting from ever-increasing demands upon healthcare systems to provide access to innovative medicines with finite or diminishing means that it has never been more important to be able to demonstrate the cost-effectiveness of new treatments.
Appropriate research and health economic analysis must be clearly communicated to key decision makers to ensure identification of resources to drive change in clinical practice and so achieve marketing success.
Understanding the evidence around your product, competitors and the disease area is crucial for you to be to able define and deliver your brand strategy and identify any evidence gaps.
JB Medical are experts in identifying evidence and advising on strategic direction.
Thanks to our detailed understanding of clinical, economic and market access agendas, coupled with our in-house ability to implement recommended analytical strategies, we are able to ensure that products reach the market with the best possible opportunities to meet the needs of both regulatory bodies and healthcare providers.
Health Technology Appraisal is a key stage in gaining market access and you will need to generate evidence to support your submissions.
JB Medical understand the needs of HTA organisations and our extensive in-house experience of disease modelling, clinical effectiveness appraisal and health economic analysis provide you with the complete array of expertise required to develop the most robust clinical and economic evidence.
Communicating your product’s value to policy makers, payors and prescribers is crucial for market access.
JB Medical understands the needs of each customer and is experienced in effectively communicating a product’s value to each audience.
We believe that medical writing should ‘tell a story’ and be backed up by the relevant evidence-base.
We have strong medical writing expertise with considerable experience in building credible and compelling clinical and health economic messages.